HomeInsightsStock Comparison

Akums Drugs Pharmaceuticals Ltd vs Venus Remedies Ltd Stock Comparison

Akums Drugs Pharmaceuticals Ltd vs Venus Remedies Ltd Stock Comparison

Last Updated on: Jun 30, 2025

Key Highlights

  • The Latest Trading Price of Akums Drugs & Pharmaceuticals Ltd is ₹ 581.7 as of 30 Jun 10:21.
  • The P/E Ratio of Akums Drugs & Pharmaceuticals Ltd changed from 21.5 on March 2025 to 21.5 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Venus Remedies Ltd changed from 5.5 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years.
  • The Market Cap of Akums Drugs & Pharmaceuticals Ltd changed from ₹ 7469 crore on March 2025 to ₹ 7469 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Venus Remedies Ltd changed from ₹ 27.77 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 years.
  • The revenue of Akums Drugs & Pharmaceuticals Ltd for the Mar '25 is ₹ 1081 crore as compare to the Dec '24 revenue of ₹ 1029 crore. This represent the growth of 5.01% The revenue of Venus Remedies Ltd for the Mar '25 is ₹ 201.73 crore as compare to the Dec '24 revenue of ₹ 188.8 crore. This represent the growth of 6.85%.
  • The ebitda of Akums Drugs & Pharmaceuticals Ltd for the Mar '25 is ₹ 119.68 crore as compare to the Dec '24 ebitda of ₹ 140.71 crore. This represent the decline of -14.95% The ebitda of Venus Remedies Ltd for the Mar '25 is ₹ 35.76 crore as compare to the Dec '24 ebitda of ₹ 30.3 crore. This represent the growth of 18.02%.
  • The net profit of Akums Drugs & Pharmaceuticals Ltd changed from ₹ -187 crore to ₹ 149.61 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Venus Remedies Ltd changed from ₹ 1.18 crore to ₹ 21 crore over 8 quarters. This represents a CAGR of 321.86% .
  • The Dividend Payout of Akums Drugs & Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Venus Remedies Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Akums Drugs & Pharmaceuticals Ltd

  • Akums Drugs and Pharmaceuticals Limited was incorporated vide Certificate of Incorporation dated April 19, 2004 and received a Certificate for Commencement of Business dated May 13, 2004 issued by the RoC. Alkums Drugs & Pharmas are a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.
  • They are into sale of branded pharmaceutical formulations and manufacturing of Active Pharmaceutical Ingredients.
  • Some of the other services include formulation research and development, preparation and filing of regulatory dossiers into the Indian and global markets, and other testing services.
  • Some of manufacturing units have been accredited by various global regulatory agencies such as the European Good Manufacturing Practice, the World Health Organization Good Manufacturing Practice and the United States National Sanitation Foundation.

About Venus Remedies Ltd

  • Incorporated in 1989 Venus Remedies Ltd (formerly known Venus Glucose Pvt Ltd), was converted into Public Limited Company in 1994 and then changed into Venus Remedies Limited.
  • The Company was promoted and managed by Chaudhary & Family.
  • The Company is one of the handful player in pharmaceutical sector to launch injectables globally.
  • It has manufacturing facilities in Panchkula and Baddi , and research and development centre under the name of Venus Medicine Research Centre (in India).
  • In priority, the Company was mainly engaged in I/V Fluids & Injectables, Ceftazidime, Amlodipine, Gliclazide, Lisinopril, etc. The production was started in 1991 with Intravenous/Intramuscular injectible forms at Panchkula district at Haryana.

Akums Drugs & Pharmaceuticals Ltd News Hub

News

Akums Drugs & Pharmaceuticals AGM scheduled

Akums Drugs & Pharmaceuticals announced that the 21st Annual General Meeting(AGM) of the c...

Read more

29 May 2025 12:07

News

Akums Drugs & Pharmaceuticals announces board meeting date

Akums Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

20 May 2025 16:59

News

Akums Drugs & Pharmaceuticals to table results

Akums Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

01 Feb 2025 17:13

News

Akums Drugs drops as IT dept conducts search at its offices & units

'Income Tax Department conducted search under the Income Tax Act, 1961 at the offices and ...

Read more

22 Jan 2025 12:07

News

Akums Drugs rallies on inking pact to supply pharmaceutical formulations in Europe

The agreement is in line with Akums growth objective of expanding in European and other re...

Read more

24 Dec 2024 13:01

News

Akums Drugs ties up with Jagdale Inds for marketing of ready-to-drink nutritional beverages

This collaboration exclusively focuses on aseptic manufacturing and subsequent filling in ...

Read more

26 Nov 2024 12:47

Venus Remedies Ltd News Hub

News

Venus Remedies to conduct board meeting

Venus Remedies will hold a meeting of the Board of Directors of the Company on 8 July 2025...

Read more

27 Jun 2025 16:28

News

Venus Remedies spurts after Q4 PAT climbs 100% YoY to Rs 21 cr

However, revenue from operations decreased marginally to Rs 194.97 crore in Q4 FY25, as ag...

Read more

27 May 2025 11:37

News

Venus Remedies to hold board meeting

Venus Remedies will hold a meeting of the Board of Directors of the Company on 26 May 2025...

Read more

17 May 2025 16:57

News

Venus Remedies jumps as investigational drug secures QIDP tag from USFDA

The drug is intended for the treatment of bloodstream infections caused by polymyxin B (PM...

Read more

17 Apr 2025 10:23

News

Venus Remedies gains on strategic MET-X partnership

MET-X, a metallo-beta-lactamase (MBL) inhibitor, targets drug-resistant Gram-negative bact...

Read more

25 Feb 2025 11:26

News

Venus Remedies hits the roof after Q3 PAT soars to Rs 20 cr

Profit before exceptional items and tax in Q3 FY25 was at Rs 14.97 crore, up 92.42% from R...

Read more

05 Feb 2025 10:35

SWOT Analysis Of Venus Remedies Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Akums Drugs & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Venus Remedies Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Akums Drugs & Pharmaceuticals Ltd and Venus Remedies Ltd

Which company has a larger market capitalization, Akums Drugs & Pharmaceuticals Ltd or Venus Remedies Ltd?

Market cap of Akums Drugs & Pharmaceuticals Ltd is 9,338 Cr while Market cap of Venus Remedies Ltd is 610 Cr

What are the key factors driving the stock performance of Akums Drugs & Pharmaceuticals Ltd and Venus Remedies Ltd?

The stock performance of Akums Drugs & Pharmaceuticals Ltd and Venus Remedies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Akums Drugs & Pharmaceuticals Ltd and Venus Remedies Ltd?

As of June 30, 2025, the Akums Drugs & Pharmaceuticals Ltd stock price is INR ₹593.35. On the other hand, Venus Remedies Ltd stock price is INR ₹456.65.

How do dividend payouts of Akums Drugs & Pharmaceuticals Ltd and Venus Remedies Ltd compare?

To compare the dividend payouts of Akums Drugs & Pharmaceuticals Ltd and Venus Remedies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions